New molecule reduces the aggressiveness of pediatric cancer

by André Julião,FAPESPA microRNA inhibitor identified by researchers at the FAPESP-supported Human Genome and Stem Cell Research Center reduced the sizes of aggressive tumors and improved

Updated on: March 06,2024

New molecule reduces the aggressiveness of pediatric cancer

by André Julião,FAPESPA microRNA inhibitor identified by researchers at the FAPESP-supported Human Genome and Stem Cell Research Center reduced the sizes of aggressive tumors and improved

Updated on:March 06,2024

AZD6738 found to slow some types of children's tumor growth in mouse models

by Bob Yirka , Medical XpressCredit: CC0 Public Domain(Medical Xpress)—A team of researchers from the U.S., Germany and Japan has found that the chemical AZD6738 was able to slow some childhood type t

Updated on: April 22,2024

AZD6738 found to slow some types of children's tumor growth in mouse models

by Bob Yirka , Medical XpressCredit: CC0 Public Domain(Medical Xpress)—A team of researchers from the U.S., Germany and Japan has found that the chemical AZD6738 was able to slow some childhood type t

Updated on:April 22,2024

Subtyping of breast cancer cell lines reveals insights into cancer-relevant genes

by Manuela Schüngel, Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbHWaterfall plot depicting recurrent non-synonymous mutations in BC cell lines. Mutations were calle

Updated on: March 30,2024

Subtyping of breast cancer cell lines reveals insights into cancer-relevant genes

by Manuela Schüngel, Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbHWaterfall plot depicting recurrent non-synonymous mutations in BC cell lines. Mutations were calle

Updated on:March 30,2024

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on: March 30,2024

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on:March 30,2024

Use of MMR deficiency testing in younger CRC patients is low

(HealthDay)—Fewer than half of younger adults with colorectal cancer (CRC) undergo mismatch repair (MMR) deficiency of DNA testing, according to a study published online Nov. 9 inJAMA Oncology.T

Updated on: April 22,2024

Use of MMR deficiency testing in younger CRC patients is low

(HealthDay)—Fewer than half of younger adults with colorectal cancer (CRC) undergo mismatch repair (MMR) deficiency of DNA testing, according to a study published online Nov. 9 inJAMA Oncology.T

Updated on:April 22,2024

Female health workers need better radiation protection to minimize breast cancer risk, find researchers

by British Medical JournalCredit: Unsplash/CC0 Public DomainWomen working in health care who are regularly exposed to radiation from X-rays and other imaging procedures need better ionizing radia

Updated on: February 01,2024

Female health workers need better radiation protection to minimize breast cancer risk, find researchers

by British Medical JournalCredit: Unsplash/CC0 Public DomainWomen working in health care who are regularly exposed to radiation from X-rays and other imaging procedures need better ionizing radia

Updated on:February 01,2024

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat

Updated on: February 01,2024

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat

Updated on:February 01,2024

Researchers explore why patients don't follow up with their doctors after receiving a positive colorectal cancer test

by American Academy of Family PhysiciansReasons for no colonoscopy after an unfavorable screening result in Dutch colorectal cancer screening: a nation-wise questionnaire. Credit:The Annals

Updated on: February 01,2024

Researchers explore why patients don't follow up with their doctors after receiving a positive colorectal cancer test

by American Academy of Family PhysiciansReasons for no colonoscopy after an unfavorable screening result in Dutch colorectal cancer screening: a nation-wise questionnaire. Credit:The Annals

Updated on:February 01,2024

Bone cells suppress cancer metastases

by Thomas Jefferson UniversityCredit: CC0 Public DomainIn breast cancer, there are cases of women and men whose cancer returns in their bones 20-30 years after they were treated for their primary

Updated on: March 30,2024

Bone cells suppress cancer metastases

by Thomas Jefferson UniversityCredit: CC0 Public DomainIn breast cancer, there are cases of women and men whose cancer returns in their bones 20-30 years after they were treated for their primary

Updated on:March 30,2024

Certain gene signaling rewires tumors after immunotherapy

by Anna Megdell,University of MichiganGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2022.12.008Researchers from the University of Michigan Rogel Cancer Center ha

Updated on: January 02,2024

Certain gene signaling rewires tumors after immunotherapy

by Anna Megdell,University of MichiganGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2022.12.008Researchers from the University of Michigan Rogel Cancer Center ha

Updated on:January 02,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on: January 02,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on:January 02,2024

Loss of cilia leads to melanoma

by University of ZurichPigment cells (blue/green) with cilium (light green with red base). Credit: Daniel Zingg, Netherlands Cancer InstituteMost cells in the human body have a cilium, a slender

Updated on: March 06,2024

Loss of cilia leads to melanoma

by University of ZurichPigment cells (blue/green) with cilium (light green with red base). Credit: Daniel Zingg, Netherlands Cancer InstituteMost cells in the human body have a cilium, a slender

Updated on:March 06,2024